TERT and cancer: But TERT promoter hypermethylation is more prevalent (>70%) in cancer types without TERT mutation (e.g., lung, breast, prostate, and colon cancers) (18, 39), implying that epigenetic mechanisms are the drivers of upregulation of TERT expression in these cancer types (40, 41).